Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study - Quiz - MDSpire

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study

  • By

  • Lukas Schaffarczyk

  • Patricia Carla Mayer

  • Axel Hamprecht

  • Philipp Thelen

  • May 18, 2026

  • 0 min

Share

Original Source(s)

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study

  • by Lukas Schaffarczyk, Patricia Carla Mayer, Axel Hamprecht, Philipp Thelen

  • May 18, 2026

Related Content

Targeting VISTA for immunomodulation in sepsis: mechanisms and therapeutic potentials

Development Process of a Clinical Decision Support System for Empiric Antibiotic Therapies in Patients With Sepsis: Case Study

Autophagy–ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine